Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion

Annals of Diagnostic Pathology

Volumn 11, Issue 4, 2007, Pages 252-257

  Ismiil, Nadia ^a   Rasty, Golnar ^a   Ghorab, Zeina ^a   Nofech Mozes, Sharon ^a   Bernardini, Marcus ^a   Ackerman, Ida ^a   Thomas, Gillian ^a   Covens, Allan ^a   Khalifa, Mahmoud A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Adenomyosis; CD10; Endometrial adenocarcinoma; Myometrial invasion

Indexed keywords

ADENOMYOSIS; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; EARLY CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; MYOMETRIUM; PATHOLOGIST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; NEPRILYSIN; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 34447278350     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2006.08.011     Document Type: Article

References (22)

1. Mariani A., Dowdy S.C., Keeney G.L., Long H.J., Lesnick T.G., and Prodratz K.C. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol 95 (2004) 120-126
2. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 35 (2004) 649-662
3. Khalifa M.A., Mannel R.S., Haraway S.D., Walker J., and Min K.-W. Expression of EGFR, Her-2/neu, p53, and PCNA in endometrioid, serous papillary and clear cell endometrial adenocarcinomas. Gynecol Oncol 53 (1994) 84-92
4. Khalifa M.A., Abdoh A.A., Mannel R.S., Haraway S.D., Walker J.L., and Min K.-W. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma. Cancer 73 (1994) 370-376
5. Stendhal U., Strang P., Wagenius G., Bergstrom R., and Tribukait B. Prognostic significance of proliferation in endometrial adenocarcinomas: a multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 10 (1991) 271-284
6. Pfisterer J., Kommoss F., Sauerbrei W., Rendl I., Kiechle M., Kleine W., et al. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Gynecol Oncol 58 (1995) 149-156
7. Lax S.F., Pizer E.S., Ronnett B.M., and Kurman R.J. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 29 (1998) 551-558
8. Winkelman J., and Robinson R. Adenocarcinoma of endometrium involving adenomyosis. Cancer 19 (1966) 901-908
9. Hall J.B., Young R.H., and Nelson Jr. J.H. The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17 (1984) 32-40
10. Hayata T., and Kawashima Y. Clinicopathologic study of eight cases of uterine body cancers associated with endometriosis interna (uterine adenomyosis). Am J Obstet Gynecol 156 (1987) 663-666
11. Taskin M., Lallas T.A., Shevchuk M., and Barber H.R.K. P53 expression in adenomyosis in endometrial carcinoma patients. Gynecol Oncol 62 (1996) 241-246
12. Koshiyama M., Okamoto T., and Ueta M. The relationship between endometrial adenocarcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri. Cancer Detect Prev 28 (2004) 94-98
13. Ronnett B.M., Zaino R.J., Ellenson L.H., and Kurman R.J. Endometrial carcinoma. In: Kurman R.J. (Ed). Blaustein's pathology of the female genital tract. 5th ed (2002), Springer-Verlag, New York 501-559
14. Nascimento A.F., Hirsch M.S., Cviko A., Quade B.J., and Nucci M.R. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol 16 (2003) 22-27
15. Mittal K.R., and Barwick K.W. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. Gynecol Oncol 49 (1993) 197-201
16. Colman H., and Rosenthal A.H. Carcinoma developing in areas of adenomyosis. Obstet Gynecol 14 (1959) 342-348
17. Giammalvo J.T., and Kaplan K. The incidence of endometriosis interna in 120 cases of carcinoma of the endometrium. Am J Obstet Gynecol 75 (1958) 161-165
18. Marcus C.C. Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. Am J Obstet Gynecol 82 (1961) 408-416
19. Williams J.W., and Hirschowitz L. Assessment of uterine wall thickness and position of the vascular plexus in the deep myometrium: implications for the measurement of depth of myometrial invasion of endometrial carcinomas. Int J Gynecol Pathol 25 (2006) 59-64
20. Chu P.G., Arber D.A., Weiss L.M., and Chang K.L. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14 (2001) 465-471
21. McCluggage W.T., Sumathi V.P., and Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stromal and of endometrial stromal neoplasms. Histopathology 39 (2001) 273-278
22. Sorodon M., Lein W.M., and Kurman R.J. CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol 27 (2003) 786-789